MX2012001767A - Intervenciones de urgencia de carbon vegetal activo con. - Google Patents

Intervenciones de urgencia de carbon vegetal activo con.

Info

Publication number
MX2012001767A
MX2012001767A MX2012001767A MX2012001767A MX2012001767A MX 2012001767 A MX2012001767 A MX 2012001767A MX 2012001767 A MX2012001767 A MX 2012001767A MX 2012001767 A MX2012001767 A MX 2012001767A MX 2012001767 A MX2012001767 A MX 2012001767A
Authority
MX
Mexico
Prior art keywords
segment
query
update operations
storage node
batch
Prior art date
Application number
MX2012001767A
Other languages
English (en)
Inventor
Andreas Clemens
Joanne Van Ryn
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of MX2012001767A publication Critical patent/MX2012001767A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/44—Elemental carbon, e.g. charcoal, carbon black
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Information Retrieval, Db Structures And Fs Structures Therefor (AREA)

Abstract

La invención se refiere a un método para tratar una sobredosificación con la sustancia activa etexilato de dabigatrán de fórmula I (ver fórmula (I)) opcionalmente en forma de sus sales farmacéuticamente aceptables, que comprende la administración de una cantidad eficaz de carbón vegetal.
MX2012001767A 2009-08-24 2010-08-23 Intervenciones de urgencia de carbon vegetal activo con. MX2012001767A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US23632109P 2009-08-24 2009-08-24
PCT/EP2010/062229 WO2011023653A1 (en) 2009-08-24 2010-08-23 Emergency interventions of active charcoal with dabigatran etexilate overdosing

Publications (1)

Publication Number Publication Date
MX2012001767A true MX2012001767A (es) 2012-02-29

Family

ID=42740360

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2012001767A MX2012001767A (es) 2009-08-24 2010-08-23 Intervenciones de urgencia de carbon vegetal activo con.

Country Status (19)

Country Link
US (2) US20110206656A1 (es)
EP (1) EP2470187B1 (es)
JP (1) JP2013502449A (es)
KR (1) KR20120050457A (es)
CN (1) CN102481317B (es)
AR (1) AR077909A1 (es)
AU (1) AU2010288601A1 (es)
BR (1) BR112012004169A2 (es)
CA (1) CA2767966A1 (es)
CL (1) CL2012000488A1 (es)
DK (1) DK2470187T3 (es)
EA (1) EA201200319A1 (es)
ES (1) ES2436076T3 (es)
IL (1) IL216968A0 (es)
MX (1) MX2012001767A (es)
NZ (1) NZ597359A (es)
PL (1) PL2470187T3 (es)
TW (1) TW201124143A (es)
WO (1) WO2011023653A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR079944A1 (es) 2010-01-20 2012-02-29 Boehringer Ingelheim Int Anticuerpo neutralizante de la actividad de un anticoagulante
SG193552A1 (en) * 2011-03-30 2013-11-29 Boehringer Ingelheim Int Anticoagulant antidotes
GB201120693D0 (en) * 2011-12-01 2012-01-11 Convatec Technologies Inc Wound dressing for use in vacuum therapy
CN114452839B (zh) * 2022-02-10 2023-04-21 中南大学湘雅医院 一种抗凝抗栓血液净化膜及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5277820A (en) * 1992-02-06 1994-01-11 Hemocleanse, Inc. Device and method for extracorporeal blood treatment
PE121699A1 (es) 1997-02-18 1999-12-08 Boehringer Ingelheim Pharma Heterociclos biciclicos disustituidos como inhibidores de la trombina
PL210862B1 (pl) 2002-03-07 2012-03-30 Boehringer Ingelheim Pharma Kompozycja farmaceutyczna w postaci peletki do doustnego podawania i sposób wytwarzania kompozycji

Also Published As

Publication number Publication date
CA2767966A1 (en) 2011-03-03
TW201124143A (en) 2011-07-16
EP2470187B1 (en) 2013-08-21
BR112012004169A2 (pt) 2016-03-29
ES2436076T3 (es) 2013-12-26
EP2470187A1 (en) 2012-07-04
NZ597359A (en) 2014-01-31
PL2470187T3 (pl) 2014-01-31
EA201200319A1 (ru) 2012-09-28
CL2012000488A1 (es) 2012-08-31
WO2011023653A1 (en) 2011-03-03
JP2013502449A (ja) 2013-01-24
US20130302311A1 (en) 2013-11-14
AR077909A1 (es) 2011-09-28
KR20120050457A (ko) 2012-05-18
CN102481317A (zh) 2012-05-30
IL216968A0 (en) 2012-02-29
AU2010288601A1 (en) 2012-02-02
CN102481317B (zh) 2014-09-03
DK2470187T3 (da) 2013-10-28
US20110206656A1 (en) 2011-08-25

Similar Documents

Publication Publication Date Title
WO2011023652A3 (en) Continuous full scan data store table and distributed data store featuring predictable answer time for unpredictable workload
MX2012001767A (es) Intervenciones de urgencia de carbon vegetal activo con.
Shukla et al. Intraperitoneal bupivacaine alone or with dexmedetomidine or tramadol for post-operative analgesia following laparoscopic cholecystectomy: A comparative evaluation
WO2018091999A1 (en) Combination of an egfr t790m inhibitor and a cdk inhibitor for the treatment of non-small cell lung cancer
JP2007530544A5 (es)
MX2024001924A (es) Benzo derivado de anillo heteroaromatico que contiene nitrogeno y uso del mismo en medicina.
EP2762480A1 (en) Oxazolidinone antibiotics containing fused ring
CN105145476A (zh) 一种山羊的养殖方法
Bandey et al. Comparison between IV paracetamol and tramadol for postoperative analgesia in patients undergoing laparoscopic cholecystectomy
JP2020529995A (ja) 行動の変化の治療方法
Chiruvella et al. Intraperitoneal instillation of ropivacaine plus dexmedetomidine for pain relief after laparoscopic hysterectomy: A comparison with ropivacaine alone
Shi et al. Intraoperative use of dexmedetomidine promotes postoperative sleep and recovery following radical mastectomy under general anesthesia
EP4279138A3 (en) Crystal of compound as c-met kinase inhibitor and preparation method therefor and use thereof
RU2016103764A (ru) Стабилизированные фармацевтические лекарственные формы, содержащие атрасентан
CN101810627A (zh) 复方磺胺间甲氧嘧啶/复方磺胺间甲氧嘧啶钠注射液及制备方法
Gebhardt et al. Using chloroprocaine for spinal anaesthesia in outpatient knee-arthroscopy results in earlier discharge and improved operating room efficiency compared to mepivacaine and prilocaine
CN103030635B (zh) 联芳基杂环取代的噁唑烷酮抗菌药
CN104644635A (zh) 一种沃替西汀药物组合物及其制备方法
Molina-Carballo et al. Treatments and compositions for attention deficit hyperactivity disorder: a patent review
ZA200504647B (en) Carbonyl-amino substituted acyl phenyl urea derivatives method for the production and use thereof
CN103275024B (zh) 一种氮唑类抗真菌化合物及其制备方法和用途
RU2646475C2 (ru) Лечение диабета I и II типа
CN103849662A (zh) 海洋内生真菌生产生物碱类物质fc的发酵方法
US8927572B2 (en) Crystal form I of salt of a dipeptidyl peptidase-IV inhibitor and preparation method and use thereof
CN201734955U (zh) 多功能药瓶

Legal Events

Date Code Title Description
FG Grant or registration